Skip to main content

Table 1 Patient characteristics

From: Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs

  Total (N) SUR + TKI (N) RT + TKI (N) RT + CHE (N) p
Male/female 12/24 6/10 4/10 2/4 0.884
Age
 Median (range) 58 (39–72) 56.5 (39–68) 57.5 (45–72) 59 (46–63) 0.767
ECOG PS
 0/1/2/3/4 20/12/4/0 12/4/0/0 6/5/3/0 2/3/1/0 0.057
RPA
 I/II/III 27/5 14/2/0 8/3/3 5/0/1 0.114
GPA
 1–2/2.5–3/3.5–4 2/20/14 0/7/9 2/8/4 0/5/1 0.264
EGFR m + type   6/10/0 (lung)    
 21/19/others 15/20/1 6/9/0 (brain) 7/6/1 2/4/0 0.934
EGFR-TKI
 Gefitinib/erlotinib 21/19 12/4 9/5 0.539
RT
 SRS/WBRT 16/4 12/2 4/2 0.355